{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:13:49Z","timestamp":1791645229505,"version":"4.3.4"},"reference-count":163,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070436"],"award-info":[{"award-number":["82070436"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiovascular diseases have been identified as vital factors in global morbidity and mortality in recent years. The available evidence suggests that various cytokines and pathological proteins participate in these complicated and changeable diseases. The thrombospondin (TSP) family is a series of conserved, multidomain calcium-binding glycoproteins that cause cell-matrix and cell-cell effects via interactions with other extracellular matrix components and cell surface receptors. The TSP family has five members that can be divided into two groups (Group A and Group B) based on their different structures. TSP-1, TSP-2, and TSP-4 are the most studied proteins. Among recent studies and findings, we investigated the functions of several family members, especially TSP-5. We review the basic concepts of TSPs and summarize the relevant molecular mechanisms and cell interactions in the cardiovascular system. Targeting TSPs in CVD and other diseases has a remarkable therapeutic benefit.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1337586","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T23:59:24Z","timestamp":1709769564000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The molecular mechanism of thrombospondin family members in cardiovascular diseases"],"prefix":"10.3389","volume":"11","author":[{"given":"Heng","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1161\/CIRCRESAHA.117.311849","article-title":"Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease","volume":"121","author":"Leong","year":"2017","journal-title":"Circ Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.biocel.2004.01.004","article-title":"The thrombospondins","volume":"36","author":"Adams","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1152\/physrev.00008.2011","article-title":"Matricellular proteins in cardiac adaptation and disease","volume":"92","author":"Frangogiannis","year":"2012","journal-title":"Physiol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/MOL.0b013e3283642912","article-title":"Thrombospondins: old players, new games","volume":"24","author":"Stenina-Adognravi","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/ijms18071540","article-title":"Thrombospondins: a role in cardiovascular disease","volume":"18","author":"Chistiakov","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/heartjnl-2020-317871","article-title":"Cardio-oncology for the general cardiologist","volume":"107","author":"Tan","year":"2021","journal-title":"Heart (Br Cardiac Soc)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/ejhf.1539","article-title":"Cancer and heart disease: associations and relations","volume":"21","author":"de Boer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"B8","doi-asserted-by":"publisher","first-page":"10617","DOI":"10.3390\/ijms231810617","article-title":"Cardio-oncology: mechanisms, drug combinations, and reverse cardio-oncology","volume":"23","author":"Liang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e13754","DOI":"10.1161\/JAHA.119.013754","article-title":"Reverse cardio-oncology: cancer development in patients with cardiovascular disease","volume":"9","author":"Aboumsallem","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/1471-2407-10-494","article-title":"Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation","volume":"10","author":"Greco","year":"2010","journal-title":"BMC Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3892\/mmr.2016.5443","article-title":"Reciprocal regulation of long noncoding rnas thbs4-003 and thbs4 control migration and invasion in prostate cancer cell lines","volume":"14","author":"Liu","year":"2016","journal-title":"Mol Med Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"a9712","DOI":"10.1101\/cshperspect.a009712","article-title":"The thrombospondins","volume":"3","author":"Adams","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.matbio.2012.01.002","article-title":"Thrombospondins in physiology and disease: new tricks for old dogs","volume":"31","author":"Murphy-Ullrich","year":"2012","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/bcpt.12026","article-title":"Thrombospondins, potential drug targets for cardiovascular diseases","volume":"112","author":"Mustonen","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0945-053X(00)00107-4","article-title":"The cell biology of thrombospondin-1","volume":"19","author":"Chen","year":"2000","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"40679","DOI":"10.1074\/jbc.M302014200","article-title":"Recognition of the n-terminal modules of thrombospondin-1 and thrombospondin-2 by alpha6beta1 integrin","volume":"278","author":"Calzada","year":"2003","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1021\/jm060833l","article-title":"Conformational analysis of an alpha3beta1 integrin-binding peptide from thrombospondin-1: implications for antiangiogenic drug design","volume":"49","author":"Furrer","year":"2006","journal-title":"J Med Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1073\/pnas.1919702117","article-title":"Matrix mechanotransduction mediated by thrombospondin-1\/integrin\/yap in the vascular remodeling","volume":"117","author":"Yamashiro","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"H745","DOI":"10.1152\/ajpheart.00237.2018","article-title":"Changes in cardiac resident fibroblast physiology and phenotype in aging","volume":"315","author":"Trial","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.matbio.2017.12.009","article-title":"Thrombospondin-1 regulation of latent tgf-\u03b2 activation: a therapeutic target for fibrotic disease","author":"Murphy-Ullrich","year":"2018","journal-title":"Matrix Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e49923","DOI":"10.7554\/eLife.49923","article-title":"Intermittent hypoxia mediated by tsp1 dependent on stat3 induces cardiac fibroblast activation and cardiac fibrosis","volume":"9","author":"Bao","year":"2020","journal-title":"Elife"},{"key":"B24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2353\/ajpath.2007.070056","article-title":"A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin ii","volume":"171","author":"Belmadani","year":"2007","journal-title":"Am J Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/neuonc\/noab212","article-title":"Tgf-\u03b2 promotes microtube formation in glioblastoma through thrombospondin 1","volume":"24","author":"Joseph","year":"2022","journal-title":"Neuro Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/CIRCULATIONAHA.116.026361","article-title":"Disturbed flow promotes arterial stiffening through thrombospondin-1","volume":"136","author":"Kim","year":"2017","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1161\/HYPERTENSIONAHA.111.175323","article-title":"Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism","volume":"58","author":"Xia","year":"2011","journal-title":"Hypertension"},{"key":"B28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.12.025","article-title":"Tumor-stroma tgf-\u03b21-thbs2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin \u03b1\u03b2\/cd36-mediated activation of the mapk pathway","volume":"528","author":"Nan","year":"2022","journal-title":"Cancer Lett"},{"key":"B29","doi-asserted-by":"publisher","first-page":"105962","DOI":"10.1016\/j.phrs.2021.105962","article-title":"Usf2 knockdown downregulates thbs1 to inhibit the tgf-\u03b2 signaling pathway and reduce pyroptosis in sepsis-induced acute kidney injury","volume":"176","author":"Sun","year":"2022","journal-title":"Pharmacol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"F871","DOI":"10.1152\/ajprenal.00209.2013","article-title":"Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity","volume":"305","author":"Cui","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/cvr\/cvz304","article-title":"Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertension","volume":"116","author":"Kumar","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41569-021-00511-w","article-title":"Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases","volume":"18","author":"Ren","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1038\/s41467-021-24215-4","article-title":"Thbs1 induces lethal cardiac atrophy through perk-atf4 regulated autophagy","volume":"12","author":"Vanhoutte","year":"2021","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1161\/01.CIR.103.4.525","article-title":"Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts","volume":"103","author":"Zhao","year":"2001","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"26069","DOI":"10.1074\/jbc.M605040200","article-title":"Cd47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1","volume":"281","author":"Isenberg","year":"2006","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"15404","DOI":"10.1074\/jbc.M701638200","article-title":"Thrombospondin-1 inhibits nitric oxide signaling via cd36 by inhibiting myristic acid uptake","volume":"282","author":"Isenberg","year":"2007","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.phrs.2010.10.014","article-title":"Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both camp and cgmp","volume":"63","author":"Yao","year":"2011","journal-title":"Pharmacol Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.matbio.2014.01.002","article-title":"Thrombospondin-1 and cd47 regulation of cardiac, pulmonary and vascular responses in health and disease","volume":"37","author":"Rogers","year":"2014","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/cvr\/cvq218","article-title":"Thrombospondin-1 supports blood pressure by limiting enos activation and endothelial-dependent vasorelaxation","volume":"88","author":"Bauer","year":"2010","journal-title":"Cardiovasc Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3389\/fphys.2018.00644","article-title":"Computer simulation of tsp1 inhibition of vegf-akt-enos: an angiogenesis triple threat","volume":"9","author":"Bazzazi","year":"2018","journal-title":"Front Physiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"38923","DOI":"10.1074\/jbc.M110.172304","article-title":"Thrombospondin-1 inhibits vegf receptor-2 signaling by disrupting its association with cd47","volume":"285","author":"Kaur","year":"2010","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/ATVBAHA.122.318904","article-title":"Cd47 activation by thrombospondin-1 in lymphatic endothelial cells suppresses lymphangiogenesis and promotes atherosclerosis","volume":"43","author":"Singla","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1161\/ATVBAHA.120.314962","article-title":"Tsp-1 (thrombospondin-1) deficiency protects apoe mice against leptin-induced atherosclerosis","volume":"41","author":"Ganguly","year":"2021","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"E1137","DOI":"10.1073\/pnas.1104357108","article-title":"Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2","volume":"108","author":"MacLauchlan","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/CIRCRESAHA.113.302749","article-title":"Thrombospondin-1: the good, the bad, and the complicated","volume":"113","author":"Ma","year":"2013","journal-title":"Circ Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/01.RES.0000141019.20332.3e","article-title":"Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy","volume":"95","author":"Schroen","year":"2004","journal-title":"Circ Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1161\/CIRCULATIONAHA.109.863266","article-title":"Absence of thrombospondin-2 causes age-related dilated cardiomyopathy","volume":"120","author":"Swinnen","year":"2009","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"H1229","DOI":"10.1152\/ajpheart.00207.2003","article-title":"Targeted deletion of mmp-2 attenuates early lv rupture and late remodeling after experimental myocardial infarction","volume":"285","author":"Hayashidani","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI8768","article-title":"Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction","volume":"106","author":"Ducharme","year":"2000","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.yjmcc.2011.05.010","article-title":"Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy","volume":"51","author":"van Almen","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.carpath.2012.03.005","article-title":"Lack of thrombospondin-2 reduces fibrosis and increases vascularity around cardiac cell grafts","volume":"22","author":"Reinecke","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1016\/j.lfs.2003.09.075","article-title":"Erk1-2 and p38 mapk regulate mmp\/timp balance and function in response to thrombospondin-1 fragments in the microvascular endothelium","volume":"74","author":"Donnini","year":"2004","journal-title":"Life Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2353\/ajpath.2008.080128","article-title":"Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis","volume":"173","author":"Krady","year":"2008","journal-title":"Am J Pathol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9670","DOI":"10.1007\/s11357-014-9670-z","article-title":"Functional changes of the coronary microvasculature with aging regarding glucose tolerance, energy metabolism, and oxidative stress","volume":"36","author":"Mourmoura","year":"2014","journal-title":"Age"},{"key":"B56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.yjmcc.2015.11.013","article-title":"Role of smooth muscle nox4-based nadph oxidase in neointimal hyperplasia","volume":"89","author":"Tong","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4103\/2045-8932.105037","article-title":"Peroxisome proliferator-activated receptor gamma (ppar\u03b3) regulates thrombospondin-1 and nox4 expression in hypoxia-induced human pulmonary artery smooth muscle cell proliferation","volume":"2","author":"Green","year":"2012","journal-title":"Pulm Circ"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/01.RES.0000020401.61826.EA","article-title":"Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function","volume":"90","author":"Csiszar","year":"2002","journal-title":"Circ Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"H1087","DOI":"10.1152\/ajpheart.00356.2009","article-title":"Aging impairs flow-induced dilation in coronary arterioles: role of no and h(2)o(2)","volume":"297","author":"Kang","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"eaaj1784","DOI":"10.1126\/scisignal.aaj1784","article-title":"The matricellular protein tsp1 promotes human and mouse endothelial cell senescence through cd47 and nox1","volume":"10","author":"Meijles","year":"2017","journal-title":"Sci Signal"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1161\/ATVBAHA.112.300031","article-title":"Thrombospondin-1 regulates blood flow via cd47 receptor-mediated activation of nadph oxidase 1","volume":"32","author":"Cs\u00e1nyi","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/ijms20030673","article-title":"Diabetes impairs angiogenesis and induces endothelial cell senescence by up-regulating thrombospondin-cd47-dependent signaling","volume":"20","author":"Bitar","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/ATVBAHA.113.301609","article-title":"Oxidative stress-mediated thrombospondin-2 upregulation impairs bone marrow-derived angiogenic cell function in diabetes mellitus","volume":"33","author":"Bae","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1681\/ASN.2013040433","article-title":"Thrombospondin-1 activation of signal-regulatory protein-\u03b1 stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury","volume":"25","author":"Yao","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/ijms23010337","article-title":"The plasminogen-activator plasmin system in physiological and pathophysiological angiogenesis","volume":"23","author":"Ismail","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1177\/0271678X211007958","article-title":"Plasminogen deficiency causes reduced angiogenesis and behavioral recovery after stroke in mice","volume":"41","author":"Fang","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"B67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/CH-2012-1565","article-title":"Decreased tsp-1 following percutaneous coronary intervention is associated with major adverse cardiac events in st-elevation myocardial infarction","volume":"54","author":"Kaiser","year":"2013","journal-title":"Clin Hemorheol Microcirc"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/ndt\/gfg159","article-title":"The thrombospondin 1-tgf-beta axis in fibrotic renal disease","volume":"18","author":"Hugo","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"B69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jcp.10454","article-title":"Latent tgf-beta1 activation by platelets","volume":"199","author":"Blakytny","year":"2004","journal-title":"J Cell Physiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.bpj.2012.06.050","article-title":"Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of tgf-\u03b21","volume":"103","author":"Venkatraman","year":"2012","journal-title":"Biophys J"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.4049\/jimmunol.177.6.3534","article-title":"Thrombospondin\/cd47 interaction: a pathway to generate regulatory t cells from human cd4\u2009+\u2009cd25- t cells in response to inflammation","volume":"177","author":"Grimbert","year":"2006","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.4049\/jimmunol.178.11.6994","article-title":"Role of thrombospondin-1 in t cell response to ocular pigment epithelial cells","volume":"178","author":"Futagami","year":"2007","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.4049\/jimmunol.178.9.5930","article-title":"Interactions between cd47 and thrombospondin reduce inflammation","volume":"178","author":"Lamy","year":"2007","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/cvr\/cvs077","article-title":"Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory t-cells","volume":"94","author":"Papageorgiou","year":"2012","journal-title":"Cardiovasc Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1161\/CIRCULATIONAHA.109.893248","article-title":"Regulatory t cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway","volume":"121","author":"Shi","year":"2010","journal-title":"Circulation"},{"key":"B76","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrcardio.2017.52","article-title":"Monocytes and macrophages in abdominal aortic aneurysm","volume":"14","author":"Raffort","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1161\/ATVBAHA.120.314913","article-title":"Myeloid-derived tsp1 (thrombospondin-1) contributes to abdominal aortic aneurysm through suppressing tissue inhibitor of metalloproteinases-1","volume":"40","author":"Yang","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1161\/CIRCRESAHA.108.185645","article-title":"Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in apoe-\/- mice","volume":"103","author":"Moura","year":"2008","journal-title":"Circ Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"19684","DOI":"10.1038\/srep19684","article-title":"Secreted thrombospondin-1 regulates macrophage interleukin-1\u03b2 production and activation through cd47","volume":"6","author":"Stein","year":"2016","journal-title":"Sci Rep"},{"key":"B80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cjca.2018.11.008","article-title":"Thrombospondin 1 is increased in the aorta and plasma of patients with acute aortic dissection","volume":"35","author":"Zeng","year":"2019","journal-title":"Can J Cardiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.matbio.2022.03.003","article-title":"Peritoneal restoration by repurposing vitamin d inhibits ovarian cancer dissemination via blockade of the tgf-\u03b21\/thrombospondin-1 axis","volume":"109","author":"Kitami","year":"2022","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"121185","DOI":"10.1016\/j.biomaterials.2021.121185","article-title":"Ecm stiffness-tuned exosomes drive breast cancer motility through thrombospondin-1","volume":"279","author":"Patwardhan","year":"2021","journal-title":"Biomaterials"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e004712","DOI":"10.1136\/jitc-2022-004712","article-title":"Targeting the cd47\/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response","volume":"10","author":"Stirling","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/mt.2013.236","article-title":"A novel cancer therapeutic using thrombospondin 1 in dendritic cells","volume":"22","author":"Weng","year":"2014","journal-title":"Mol Therapy"},{"key":"B85","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41467-018-08026-8","article-title":"Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability","volume":"10","author":"Schips","year":"2019","journal-title":"Nat Commun"},{"key":"B86","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00395-013-0374-9","article-title":"Deficiency of cartilage oligomeric matrix protein causes dilated cardiomyopathy","volume":"108","author":"Huang","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of p38 mapk signalling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem J"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1084\/jem.20172063","article-title":"Selective inhibition of the p38\u03b1 mapk-mk2 axis inhibits inflammatory cues including inflammasome priming signals","volume":"215","author":"Wang","year":"2018","journal-title":"J Exp Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.110.232371","article-title":"Thrombospondin-4 regulates vascular inflammation and atherogenesis","volume":"107","author":"Frolova","year":"2010","journal-title":"Circ Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1161\/01.CIR.0000089085.76320.4E","article-title":"Thrombospondin-4 and its variants: expression and differential effects on endothelial cells","volume":"108","author":"Stenina","year":"2003","journal-title":"Circulation"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1161\/ATVBAHA.115.305912","article-title":"Proangiogenic properties of thrombospondin-4","volume":"35","author":"Muppala","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41419-018-0703-x","article-title":"Comp-prohibitin 2 interaction maintains mitochondrial homeostasis and controls smooth muscle cell identity","volume":"9","author":"Jia","year":"2018","journal-title":"Cell Death Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/CIRCRESAHA.109.202762","article-title":"Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with alpha(7)beta(1) integrin","volume":"106","author":"Wang","year":"2010","journal-title":"Circ Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/01.ATV.21.1.47","article-title":"Cartilage oligomeric matrix protein (thrombospondin-5) is expressed by human vascular smooth muscle cells","volume":"21","author":"Riessen","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.matbio.2020.10.003","article-title":"Cartilage oligomeric matrix protein fine-tunes disturbed flow-induced endothelial activation and atherogenesis","volume":"95","author":"Lv","year":"2021","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/cr.2008.326","article-title":"Tgf-beta signaling in vascular biology and dysfunction","volume":"19","author":"Goumans","year":"2009","journal-title":"Cell Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1038\/onc.2017.140","article-title":"Thrombospondin-4 mediates tgf-\u03b2-induced angiogenesis","volume":"36","author":"Muppala","year":"2017","journal-title":"Oncogene"},{"key":"B98","doi-asserted-by":"publisher","first-page":"43250","DOI":"10.1074\/jbc.M111.234716","article-title":"Enhanced activity of transforming growth factor \u03b21 (tgf-\u03b21) bound to cartilage oligomeric matrix protein","volume":"286","author":"Haudenschild","year":"2011","journal-title":"J Biol Chem"},{"key":"B99","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/ard.2007.086850","article-title":"Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta","volume":"68","author":"Farina","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.matbio.2018.01.025","article-title":"New developments on skin fibrosis\u2014essential signals emanating from the extracellular matrix for the control of myofibroblasts","author":"Schulz","year":"2018","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1161\/CIRCRESAHA.110.234328","article-title":"Cartilage oligomeric matrix protein inhibits vascular smooth muscle calcification by interacting with bone morphogenetic protein-2","volume":"108","author":"Du","year":"2011","journal-title":"Circ Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2012.03.050","article-title":"A thrombospondin-dependent pathway for a protective er stress response","volume":"149","author":"Lynch","year":"2012","journal-title":"Cell"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e00114","DOI":"10.1128\/MCB.00114-18","article-title":"Defective flux of thrombospondin-4 through the secretory pathway impairs cardiomyocyte membrane stability and causes cardiomyopathy","volume":"38","author":"Brody","year":"2018","journal-title":"Mol Cell Biol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/CIRCRESAHA.112.280560","article-title":"Atf6 [corrected] and thrombospondin 4: the dynamic duo of the adaptive endoplasmic reticulum stress response","volume":"112","author":"Doroudgar","year":"2013","journal-title":"Circ Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"H1486","DOI":"10.1152\/ajpheart.00046.2016","article-title":"Thrombospondin-4 knockout in hypertension protects small-artery endothelial function but induces aortic aneurysms","volume":"310","author":"Palao","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0002-9440(10)63634-6","article-title":"Mutation (d472y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis","volume":"163","author":"Hashimoto","year":"2003","journal-title":"Am J Pathol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.121.17972","article-title":"Comp (cartilage oligomeric matrix protein), a novel piezo1 regulator that controls blood pressure","volume":"79","author":"Wang","year":"2022","journal-title":"Hypertension"},{"key":"B108","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41419-020-2237-2","article-title":"Effects of thrombospondin-4 on pro-inflammatory phenotype differentiation and apoptosis in macrophages","volume":"11","author":"Rahman","year":"2020","journal-title":"Cell Death Dis"},{"key":"B109","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2016.02.005","article-title":"Thrombospondin-4 ablation reduces macrophage recruitment in adipose tissue and neointima and suppresses injury-induced restenosis in mice","volume":"247","author":"Lv","year":"2016","journal-title":"Atherosclerosis"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.bbrc.2016.08.004","article-title":"Cartilage oligomeric matrix protein prevents vascular aging and vascular smooth muscle cells senescence","volume":"478","author":"Wang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B111","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2174\/1570161115666170201121232","article-title":"Cartilage oligomeric matrix protein: matricellular and matricrine signaling in cardiovascular homeostasis and disease","volume":"15","author":"Fu","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/CIRCRESAHA.115.308021","article-title":"Shift of macrophage phenotype due to cartilage oligomeric matrix protein deficiency drives atherosclerotic calcification","volume":"119","author":"Fu","year":"2016","journal-title":"Circ Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jdi.14095","article-title":"Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus","volume":"15","author":"Guo","year":"2024","journal-title":"J Diabetes Investig"},{"key":"B114","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12931-016-0412-x","article-title":"The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension","volume":"17","author":"Kaiser","year":"2016","journal-title":"Respir Res"},{"key":"B115","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7555\/JBR.29.20140025","article-title":"Circulating thrombospondine-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease","volume":"2","author":"Berezin","year":"2015","journal-title":"J Biomed Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1038\/s41467-019-13306-y","article-title":"Profiling of the plasma proteome across different stages of human heart failure","volume":"10","author":"Egerstedt","year":"2019","journal-title":"Nat Commun"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/ejhf.2291","article-title":"Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction","volume":"23","author":"Kresoja","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B118","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12933-022-01646-x","article-title":"Prospective associations of circulating thrombospondin-2 level with heart failure hospitalization, left ventricular remodeling and diastolic function in type 2 diabetes","volume":"21","author":"Lee","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"291","DOI":"10.31083\/j.fbl2710291","article-title":"Correlation between low thbs3 expression in peripheral blood and acute myocardial infarction","volume":"27","author":"Chen","year":"2022","journal-title":"Front Biosci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s12872-021-02322-w","article-title":"Association of atrial arrhythmias with thrombospondin-1 in patients with acute myocardial infarction","volume":"21","author":"Liao","year":"2021","journal-title":"Bmc Cardiovasc Disord"},{"key":"B121","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jprot.2014.07.016","article-title":"Proteomic characterization of human coronary thrombus in patients with st-segment elevation acute myocardial infarction","volume":"109","author":"Alonso-Orgaz","year":"2014","journal-title":"J Proteomics"},{"key":"B122","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3892\/etm.2020.9279","article-title":"Thrombospondin-2 is upregulated in patients with aortic dissection and enhances angiotensin ii-induced smooth muscle cell apoptosis","volume":"20","author":"Qi","year":"2020","journal-title":"Exp Ther Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/ATVBAHA.110.220624","article-title":"Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties","volume":"31","author":"Smadja","year":"2011","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1177\/00033197231166492","article-title":"New biomarkers (endocan, interleukin-17, and thrombospondin-4) for the diagnosis, assessment of severity, and follow-up of peripheral arterial disease","volume":"74","author":"Yazman","year":"2023","journal-title":"Angiology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/gm517","article-title":"Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases","volume":"5","author":"Prentice","year":"2013","journal-title":"Genome Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"87","DOI":"10.11909\/j.issn.1671-5411.2017.02.002","article-title":"Altered serum level of cartilage oligomeric matrix protein and its association with coronary calcification in patients with coronary heart disease","volume":"14","author":"Wang","year":"2017","journal-title":"J Geriatr Cardiol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2011.10.003","article-title":"Increased thrombospondin-2 in human fibrosclerotic and stenotic aortic valves","volume":"220","author":"Pohjolainen","year":"2012","journal-title":"Atherosclerosis"},{"key":"B128","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.12659\/MSM.898889","article-title":"New markers in atherosclerosis: thrombospondin-2 (thbs-2) and leukocyte cell-derived chemotaxin-2 (lect-2); an immunohistochemical study","volume":"22","author":"Sonmez","year":"2016","journal-title":"Med Sci Monit"},{"key":"B129","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.atherosclerosis.2011.08.013","article-title":"Proteomic analysis of intra-arterial thrombus secretions reveals a negative association of clusterin and thrombospondin-1 with abdominal aortic aneurysm","volume":"219","author":"Moxon","year":"2011","journal-title":"Atherosclerosis"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.amjcard.2013.02.038","article-title":"Relation between serum thrombospondin-2 and cardiovascular mortality in older men screened for abdominal aortic aneurysm","volume":"111","author":"Golledge","year":"2013","journal-title":"Am J Cardiol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"8043135","DOI":"10.1155\/2020\/8043135","article-title":"Thrombospondin-1: a key protein that induces fibrosis in diabetic complications","volume":"2020","author":"Xu","year":"2020","journal-title":"J Diabetes Res"},{"key":"B132","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12882-023-03216-z","article-title":"Extracellular status of thrombospondin-2 in type 2 diabetes mellitus and utility as a biomarker in the determination of early diabetic kidney disease","volume":"24","author":"Lin","year":"2023","journal-title":"Bmc Nephrol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4070\/kcj.2012.42.2.100","article-title":"Higher plasma thrombospondin-1 levels in patients with coronary artery disease and diabetes mellitus","volume":"42","author":"Choi","year":"2012","journal-title":"Korean Circ J"},{"key":"B134","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3324\/haematol.2014.119727","article-title":"Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea","volume":"100","author":"Lopes","year":"2015","journal-title":"Haematologica"},{"key":"B135","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00018-007-7484-1","article-title":"Structures of thrombospondins","volume":"65","author":"Carlson","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"B136","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1124\/mol.55.2.332","article-title":"Three distinct d-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat","volume":"55","author":"Dawson","year":"1999","journal-title":"Mol Pharmacol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/TP.0b013e318160500a","article-title":"Antiangiogenic treatment prevents adventitial constrictive remodeling in graft arteriosclerosis","volume":"85","author":"Thaunat","year":"2008","journal-title":"Transplantation"},{"key":"B138","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000113790","article-title":"Thrombospondin 1 and its mimetic peptide abt-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease","volume":"75","author":"Punekar","year":"2008","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/annonc\/mdl102","article-title":"A phase i study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor abt-510 with gemcitabine and cisplatin in patients with solid tumors","volume":"17","author":"Gietema","year":"2006","journal-title":"Ann Oncol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1200\/JCO.2008.17.4706","article-title":"Randomized, phase ii study of the thrombospondin-1-mimetic angiogenesis inhibitor abt-510 in patients with advanced soft tissue sarcoma","volume":"26","author":"Baker","year":"2008","journal-title":"J Clin Oncol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1593\/neo.91880","article-title":"The thrombospondin-1 mimetic abt-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancer","volume":"12","author":"Campbell","year":"2010","journal-title":"Neoplasia"},{"key":"B142","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/cam4.65","article-title":"A phase I study of abt-510 plus bevacizumab in advanced solid tumors","volume":"2","author":"Uronis","year":"2013","journal-title":"Cancer Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ejca.2005.08.040","article-title":"Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor abt-510 with 5-fluorouracil and leucovorin: a safe combination","volume":"42","author":"Hoekstra","year":"2006","journal-title":"Eur J Cancer"},{"key":"B144","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1158\/1078-0432.CCR-07-1477","article-title":"Phase 2 study of abt-510 in patients with previously untreated advanced renal cell carcinoma","volume":"13","author":"Ebbinghaus","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B145","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/01.RES.0000259579.35787.4e","article-title":"Increasing survival of ischemic tissue by targeting cd47","volume":"100","author":"Isenberg","year":"2007","journal-title":"Circ Res"},{"key":"B146","doi-asserted-by":"publisher","first-page":"e137345","DOI":"10.1016\/j.ajpath.2011.02.039","article-title":"Pre-clinical development of a humanized anti-cd47 antibody with anti-cancer therapeutic potential","volume":"10","author":"Liu","year":"2015","journal-title":"Plos One"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1016\/j.ajpath.2011.02.039","article-title":"Blockade of tsp1-dependent tgf-\u03b2 activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy","volume":"178","author":"Lu","year":"2011","journal-title":"Am J Pathol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/bjs.9765","article-title":"Effect of lskl peptide on thrombospondin 1-mediated transforming growth factor \u03b2 signal activation and liver regeneration after hepatectomy in an experimental model","volume":"102","author":"Kuroki","year":"2015","journal-title":"Br J Surg"},{"key":"B149","doi-asserted-by":"publisher","first-page":"109824","DOI":"10.1016\/j.biopha.2020.109824","article-title":"Investigating the potential of lskl peptide as a novel hypertrophic scar treatment","volume":"124","author":"Xu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"B150","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1161\/ATVBAHA.114.304732","article-title":"A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin ii-infused apolipoprotein-e-deficient mouse","volume":"35","author":"Krishna","year":"2015","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/eurjpc\/zwab084","article-title":"Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study","volume":"29","author":"Jain","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12872-018-0932-z","article-title":"Incidence of new onset cancer in patients with a myocardial infarction\u2014a nationwide cohort study","volume":"18","author":"Malmborg","year":"2018","journal-title":"Bmc Cardiovasc Disord"},{"key":"B153","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/cvr\/cvz035","article-title":"Common risk factors for heart failure and cancer","volume":"115","author":"Meijers","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B154","doi-asserted-by":"publisher","first-page":"8975","DOI":"10.1074\/jbc.M114.624965","article-title":"Photodynamic therapy-mediated cancer vaccination enhances stem-like phenotype and immune escape, which can be blocked by thrombospondin-1 signaling through cd47 receptor protein","volume":"290","author":"Zheng","year":"2015","journal-title":"J Biol Chem"},{"key":"B155","doi-asserted-by":"publisher","first-page":"8133","DOI":"10.3390\/curroncol29110642","article-title":"Cd36 and its role in regulating the tumor microenvironment","volume":"29","author":"Liao","year":"2022","journal-title":"Curr Oncol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1182\/blood-2004-09-3585","article-title":"Type 3 repeat\/c-terminal domain of thrombospondin-1 triggers caspase-independent cell death through cd47\/alphavbeta3 in promyelocytic leukemia nb4 cells","volume":"106","author":"Saumet","year":"2005","journal-title":"Blood"},{"key":"B157","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1158\/1078-0432.CCR-06-1758","article-title":"Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis","volume":"13","author":"Roberts","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B158","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13046-020-01812-7","article-title":"Thrombospondin 4\/integrin \u03b12\/hsf1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells","volume":"40","author":"Shi","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B159","doi-asserted-by":"publisher","first-page":"98298","DOI":"10.18632\/oncotarget.21176","article-title":"Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis","volume":"8","author":"Englund","year":"2017","journal-title":"Oncotarget"},{"key":"B160","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.3390\/ijms22094570","article-title":"Functions of thrombospondin-1 in the tumor microenvironment","volume":"22","author":"Kaur","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B161","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1002\/ijc.33439","article-title":"Thrombospondin-4 mediates hyperglycemia- and tgf-beta-induced inflammation in breast cancer","volume":"148","author":"Muppala","year":"2021","journal-title":"Int J Cancer"},{"key":"B162","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41422-020-00464-8","article-title":"Cartilage oligomeric matrix protein is an endogenous \u03b2-arrestin-2-selective allosteric modulator of at1 receptor counteracting vascular injury","volume":"31","author":"Fu","year":"2021","journal-title":"Cell Res"},{"key":"B163","doi-asserted-by":"publisher","first-page":"9253","DOI":"10.3390\/ijms23169253","article-title":"Cartilage oligomeric matrix protein, diseases, and therapeutic opportunities","volume":"23","author":"Cui","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1337586\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T23:59:30Z","timestamp":1709769570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1337586\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":163,"alternative-id":["10.3389\/fcvm.2024.1337586"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1337586","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"article-number":"1337586"}}